Login / Signup

Beta-Lactam Plus Macrolide for Patients Hospitalized With Community-Acquired Pneumonia: Difference Between Autumn and Spring.

Yoon Jung KimYe-Na JeonKi Tae KwonShin-Woo KimSoyoon HwangHyun Ha ChangShin-Woo KimWon Kee LeeKi-Hwa YangJi Hyeon ShinEun-Kyung Shim
Published in: Journal of Korean medical science (2022)
Beta-lactam plus macrolide combination therapy shows potential as an empirical therapy for CAP with CURB-65 ≥ 2, especially in autumn.
Keyphrases
  • combination therapy
  • community acquired pneumonia
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis
  • climate change